Geranylgeranyl pyrophosphate
Names | |
---|---|
IUPAC name
(2E,4E,6E)-3,5,7,11-Tetramethyldodeca-2,4,6,10-tetraene-1-pyrrophosphate | |
Identifiers | |
6699-20-3 | |
ChEBI | CHEBI:48861 |
ChemSpider | 394418 |
3052 | |
Jmol interactive 3D | Image |
MeSH | geranylgeranyl+pyrophosphate |
PubChem | 447277 |
| |
| |
Properties | |
C20H36O7P2 | |
Molar mass | 450.45 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Geranylgeranyl pyrophosphate is an intermediate in the HMG-CoA reductase pathway used by organisms in the biosynthesis of terpenes and terpenoids.[1] In plants it is also the precursor to carotenoids, gibberellins, tocopherols, and chlorophylls.
It is also a precursor to geranylgeranylated proteins, which is its primary use in human cells. [2]
In Drosophila, geranylgeranyl pyrophosphate is synthesised by HMG-CoA encoded by the Columbus gene. Geranylgeranyl pyrophosphate is utilised as a chemoattractant for migrating germ cells that have traversed the midgut epithelia. The attractant signal is produced at the gonadal precursors, directing the germ cells to these sites, where they will differentiate into ova (eggs) and spermatozoa (sperm).
Related compounds
References
- ↑ Cholesterol Synthesis, Rensselaer Polytechnic Institute]
- ↑ Wiemer, AJ; Wiemer, DF; Hohl, RJ (December 2011). "Geranylgeranyl diphosphate synthase: an emerging therapeutic target.". Clinical pharmacology and therapeutics 90 (6): 804–12. doi:10.1038/clpt.2011.215. PMID 22048229.
|
This article is issued from Wikipedia - version of the Tuesday, August 18, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.